Molecular Neurodegeneration is an open access, peer-reviewed online journal that will encompass all aspects of neurodegeneration research at the molecular and cellular levels.
Dr. Huaxi Xu is the co-Editor-in-Chief of Molecular Neurodegeneration.
Dr. Huaxi Xu
Burnham Institute for Medical Research
Dr. Huaxi Xu is Professor and Acting Director of Degenerative Disease Program at Burnham Institute for Medical Research. He has made several important contributions to pathogenesis of Alzheimer’s diseases. Dr.Huaxi Xu’s researches focus on the molecular and cellular mechanisms underlying Aß generation. He hopes that the insights from these studies can translate into effective therapies for the treatment or prevention of AD. He has received many honors, including Zenith Fellow Award (2007), Ellison Medical Foundation New Scholars in Aging Award, and “The Ruth Salta Junior Investigator Achievement Award”. He is a Member of NIH Study Section (CDIN) and has served on many NIH grant review panels including NIH ICI Study Section, NIH/NIA SEP (AD drug discovery.
To see profiles of some of the other Editors who have chosen to bring their journal to BioMed Central please see the independent journals' Editor profiles.
Advertisements appearing on this page are the responsibility of BioMed Central and do not constitute endorsement by the journals or their editors
